Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.
Former Senior Nutrition Scientist (Dec 2022 - Oct 2025); India
Discover how evidence-based nutrition science, public-private partnerships, and technical innovation are transforming food systems and improving child nutrition in India. Dive in to learn how real-world solutions drive policy, product success, and lasting impact. Read the full article!
Vice President- Market Access and Hospital Business (CCD and Nephrology) (Apr 2025 – Present); India
Learn how digital health, new therapies, and payer partnerships are transforming access in emerging markets. Read the article for a deeper dive.
Corporate Quality Assurance Manager – Pharmaceuticals (Mar 2023 - Present); India
A real world view on pharmaceutical quality, sharing how early compromises, documentation gaps, vendor risks, and human behavior quietly evolve into recurring compliance and patient safety issues.
Head – IT Service Delivery (Jan 2023 – Present)
Digital health growth is accelerating unevenly, driven by consumer-grade experiences and selective tech adoption, while regulatory discipline, data trust, and execution depth increasingly determine which healthcare technology providers achieve sustainable advantage.
Director & Enterprise Architect - Healthcare & Life Sciences (Oct 2024 - Present); India
This article talks about digital transformation strategies, AI adoption, and architectural best practices for healthcare and life sciences enterprises, focusing on sustainable innovation, compliance, and human-centered design.
Senior Business Development Manager - Biopharma, Asia Pacific (APAC) (Nov 2022 – Present)
Discover why global pharma leaders are turning to APAC markets like India and Vietnam. Learn how innovation in cell/gene therapy, automation, and biosimilars is reshaping the industry. Read on to stay ahead in the evolving CDMO/CRO landscape!